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Patient autonomy or patient confusion?
A couple of weekends ago a friend, Richard, popped 
in for a cup of tea – a very fit, active septuagenarian 
who rides the Cape Argus Pick n Pay Cycle Tour every 
year and has recently started running. A few years ago 
he had a triple bypass. At the time, his cardiologist 
told him that, ‘From today, you become a vegetarian ... ’. According to 
Richard, the cardiologist told him to cut out eggs, butter, red meat and 
any source of saturated fats from his diet; standard advice that we have 
all given at some stage in our careers. Richard’s problem, though, was 
this: ‘Now’ he says, ‘I am told that margarine is actually bad for me, eggs 
are fine and there are even people saying that it is OK to eat saturated 
fats – who is right? What do I do?’
Scanning the popular medical press over the past few months 
would only have added to Richard’s confusion – with headlines 
such as: ‘New analysis suggests whole diet approach to lower 
cardiovascular risk has more evidence than low-fat diets’;[1] ‘Butter 
is bad – a myth we’ve been fed by the “healthy eating” industry’.[2] I 
would imagine that many doctors are confused – just think how your 
patients must be feeling.
Along with the furore about possibly modifying ‘healthy eating’ 
guidelines (never mind the heated debate over fats v. carbohydrates), 
we have conflicting advice on the globally popular, bestselling 
cholesterol drugs – the statins – from: ‘Taking statins to lower 
cholesterol? New guidelines provide opportunity to discuss options 
with your doctor’ – Mayo Clinic;[3] ‘Low-dose statins good option 
for some heart patients, study finds’ – Medical Xpress;[4] to the 
confusing alternative: ‘Cholesterol drug statins should be given to 
millions more, [National Health Service (NHS)] guidance says’ – The 
Guardian.[5]
We live in an era of patient autonomy; the idea being to involve our 
patients more in their care. All well and good, and certainly better 
than the paternalistic attitude that was prevalent a few decades ago, 
but what is it that we are expecting patients to do? 
The Mayo Clinic,[3] based on a commentary by three of their 
physicians published recently in JAMA[6] on the 2013 American 
College of Cardiology and American Medical Association 
cardiovascular guidelines,[7] informs the the reader – assumed to 
be a layperson – that ‘clinicians and patients should use shared 
decision-making to select individualised treatments based on the new 
guidelines to prevent cardiovascular disease’. 
They add, ‘Shared decision-making is a collaborative process that 
allows patients and their clinicians to make health care decisions 
together, taking into account the best scientific evidence available, 
as well as the patient’s values and preferences.’ The new guidelines 
recommend that anyone with a ‘10-year cardiovascular risk of 
7.5% or higher’ is offered statins. But, the article goes on to say, 
‘[commentator] Dr Montori cautions that the risk threshold 
established by the guideline panel is somewhat arbitrary. Instead he 
recommends that patients and their clinicians use a decision-making 
tool to discuss the risks and benefits of treatment with statins’. 
This same learned gentleman adds that rather than routinely 
prescribing statins to the millions of adults who have at least a 7.5% 
risk of having a heart attack or stroke within 10 years, clinicians and 
patients should discuss the potential harms and burdens of statins to 
arrive at a decision that ‘reflects the existing research and the values 
and context of each patient’. He goes on to say – very tellingly in my 
opinion – ‘ ... we move the decision-making from the scientist to the 
patient ... ’. 
Conversely, the article in The Guardian,[5] arguably read by fairly 
well-educated people, explains that new NHS guidance says that 
everyone who has only a low risk of heart disease or stroke should be 
offered statins, already taken by some 7 million people in England. 
The National Institute for Health and Care Excellence (NICE), itself 
rather a paternalistic outfit, is now telling British GPs that they should 
prescribe – not offer – statins to all those with a 10% risk of heart 
disease and stroke, dropped from the previous threshold of 20%, and 
different again from the US threshold of 7.5%.[8]
Many doctors find it difficult to interpret guidelines – all based 
on relatively complex statistical analyses derived from drug trials, 
many of which used different methods of analysis and all of which 
talk about percentage risk, relative risk, confidence limits, number 
needed to treat, hazard ratios, etc. – which, with the best will in the 
world, most of us cannot interpret 
easily. Yet, we are asking our patients 
to make decisions ‘in consultation’ 
based on tools developed using these 
statistics? 
In my opinion, we need to think again 
about exactly what patient autonomy 
means and make sure that we don’t 
simply offer confusion.
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